APO-LAMIVUDINE-ZIDOVUDINE
APO-LAMIVUDINE-ZIDOVUDINE
Approved
DIN Number
02375540
Drug Class
Human
Market Date
Jun 4, 2012
Company
HC
Apotex Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02375540
AIG Number0235460001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR01 ZIDOVUDINE AND LAMIVUDINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.20
Health Canada Classification
ACTIVE INGREDIENTS (2)
LAMIVUDINEActive
Strength: 150 MG
Monograph: LAMIVUDINE
ZIDOVUDINEActive
Strength: 300 MG
Monograph: ZIDOVUDINE